MarketCap
Facebook
X
TelegramAnnual report 2023
added 03-08-2024
Emergent BioSolutions Operating Cycle 2011-2026 | EBS
Annual Operating Cycle Emergent BioSolutions
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 237 | 255 | 211 | 238 | 278 | 360 | 361 | 317 | 315 | 251 | 163 | 244 | 239 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 361 | 163 | 267 |
Quarterly Operating Cycle Emergent BioSolutions
| 2023-Q3 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 245 | - | 200 | - | 67.7 | - | 71.6 | 210 | 383 | 36.1 | 243 | 269 | 433 | 68.5 | 267 | 303 | 341 | 88.5 | 409 | 329 | 450 | 67.7 | 381 | 506 | 110 | 83.3 | 88.4 | 138 | 112 | 65 | 67.6 | 87.4 | 129 | 36.3 | 38.9 | 48.7 | 101 | 56.4 | 62 | 67.1 | 166 | 92.6 | 132 | 125 | 154 | 62.7 | 115 | 76.8 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 506 | 36.1 | 169 |
Operating Cycle of other stocks in the Drug manufacturers industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agile Therapeutics
AGRX
|
146 | - | 10.11 % | $ 58.2 M |  USA |
 |
AcelRx Pharmaceuticals
ACRX
|
16.5 | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
121 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
576 | - | - | $ 754 M | USA |
 |
Assertio Holdings
ASRT
|
590 | $ 18.02 | - | $ 115 M | USA |
 |
Catalent
CTLT
|
152 | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
560 | - | - | $ 50.1 M | USA |
 |
Alimera Sciences
ALIM
|
181 | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
247 | - | -23.39 % | $ 1.76 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
214 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
180 | - | - | $ 28.9 M |  Irlanda |
 |
Avadel Pharmaceuticals plc
AVDL
|
416 | - | - | $ 2.06 B |  France |
 |
Evoke Pharma
EVOK
|
45.7 | - | - | $ 36.6 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
614 | $ 3.09 | -0.64 % | $ 43.4 M | USA |
 |
Cronos Group
CRON
|
425 | $ 2.58 | 1.18 % | $ 1.34 B |  Canada |
 |
HEXO Corp.
HEXO
|
775 | - | 2.45 % | $ 38.1 M | Canada |
 |
Bausch Health Companies
BHC
|
78.9 | $ 5.6 | 3.9 % | $ 2.04 B | Canada |
 |
Harrow Health
HROW
|
217 | $ 35.93 | -3.65 % | $ 1.32 B | USA |
 |
Aurora Cannabis
ACB
|
1.45 K | $ 3.43 | -1.44 % | $ 86.3 M | Canada |
 |
Canopy Growth Corporation
CGC
|
230 | $ 1.05 | -3.67 % | $ 113 M | Canada |
 |
Jupiter Wellness
JUPW
|
112 | - | - | $ 33.6 M | USA |
 |
OrganiGram Holdings
OGI
|
2.92 K | $ 1.4 | -2.78 % | $ 402 M | Canada |
 |
Lannett Company
LCI
|
210 | - | 1.15 % | $ 7.11 M | USA |
 |
Evolus
EOLS
|
134 | $ 4.27 | 0.71 % | $ 275 M | USA |
 |
Organogenesis Holdings
ORGO
|
159 | $ 2.38 | 3.93 % | $ 313 M | USA |
 |
Pacira BioSciences
PCRX
|
246 | $ 23.79 | -0.13 % | $ 1.1 B | USA |
 |
PetIQ
PETQ
|
108 | - | 1.64 % | $ 400 M | USA |
 |
ProPhase Labs
PRPH
|
141 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
220 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
112 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
508 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
106 | $ 1.0 | 0.81 % | $ 49.9 M | USA |
 |
PLx Pharma
PLXP
|
111 | - | -27.8 % | $ 2.56 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
182 | $ 2.28 | -5.39 % | $ 2.83 M | USA |
 |
Tilray
TLRY
|
222 | $ 6.57 | -2.23 % | $ 4.06 B | Canada |
 |
Veru
VERU
|
271 | $ 2.38 | -2.06 % | $ 321 M | USA |
 |
Viatris
VTRS
|
219 | $ 13.47 | -1.03 % | $ 16.2 B | USA |
 |
cbdMD
YCBD
|
176 | $ 0.68 | 4.01 % | $ 2.93 M | USA |
 |
Zomedica Corp.
ZOM
|
218 | - | -0.21 % | $ 98 M | USA |
 |
Rockwell Medical
RMTI
|
72.5 | $ 0.91 | -2.17 % | $ 32.7 M | USA |
 |
China Pharma Holdings
CPHI
|
187 | $ 0.63 | -3.82 % | $ 2.7 M |  China |
 |
TherapeuticsMD
TXMD
|
3.34 K | $ 2.07 | 0.98 % | $ 23.9 M | USA |